About Tregenesis Sciences
Tregenesis Sciences is a company based in Hyderabad (India). It operates as a B2B. Tregenesis Sciences offers products and services including Mesagran, Benztre, Lyoflora, Xifatre, and Duofiber. Tregenesis Sciences operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter Hyderabad, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Tregenesis Sciences Private Limited
- Date of Incorporation 23 Jun, 2016
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$589.19 K (USD)46.77as on Mar 31, 2023
-
Net Profit
$13.13 K (USD)104.01as on Mar 31, 2023
-
EBITDA
$15.78 K (USD)172.95as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tregenesis Sciences
Tregenesis Sciences offers a comprehensive portfolio of products and services, including Mesagran, Benztre, Lyoflora, Xifatre, and Duofiber.
Treatment for gastrointestinal inflammatory conditions
Therapy for digestive system disorders
Support for gut health and related issues
Medication targeting bowel diseases
Aid for gastrointestinal symptoms and management
Funding Insights of Tregenesis Sciences
Detailed funding history for Tregenesis Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tregenesis Sciences
Investment portfolio details for Tregenesis Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tregenesis Sciences
Detailed financials for Tregenesis Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tregenesis Sciences Comparisons
Peer comparison for Tregenesis Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tregenesis Sciences
Tregenesis Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Tregenesis Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tregenesis Sciences
Complete news archive for Tregenesis Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tregenesis Sciences
Tregenesis Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of Tregenesis Sciences is $589.19K as on Mar 31, 2023.
Tregenesis Sciences is a global pharmaceutical company focused on improving gastrointestinal health through research-driven innovation. They develop and market treatments for diseases like inflammatory bowel disease, ulcerative colitis, and Crohns, collaborating with healthcare professionals. Based in India, they emphasize sustainability, ethical conduct, and community partnerships to enhance patient care and access to medicines.
Tregenesis Sciences's top competitors include Merck, Roivant Sciences and AbbVie.
Tregenesis Sciences offers Mesagran, Benztre, Lyoflora, Xifatre, and Duofiber.